Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Large National Network of Ambulatory Surgical Centers Doubles Order of STREAMWAY Systems
Skyline Medical's STREAMWAY System is Preferred Fluid Management System for Surgical Centers around the U.S.
View HTML
Toggle Summary Latest Skyline Medical Installations Reinforce Increasing Standardization of Safer Closed Fluid Waste Management System View HTML
Toggle Summary Leading Proxy Advisory Firm Glass, Lewis Recommends Stockholders Vote FOR Skyline Medical Management Proposals
MINNEAPOLIS, Aug. 24, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports that Glass, Lewis & Co., Inc. recommends that stockholders vote FOR management
View HTML
Toggle Summary Leading Proxy Advisory Firm Glass, Lewis Recommends Stockholders Vote FOR Skyline Medical Management Proposals View HTML
Toggle Summary Leading Proxy Advisory Firm ISS Recommends Stockholders Vote FOR Skyline Medical Management Proposals
MINNEAPOLIS, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports that Institutional Shareholder Services, Inc.
View HTML
Toggle Summary Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018
Sixteen STREAMWAY Systems sold in Q1 2018, compared with five units sold in Q4 2017 and three sold in Q1 2016 MINNEAPOLIS , March 29, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), today provided a sales update from its Skyline Medical division,
View HTML
Toggle Summary Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board
MINNEAPOLIS , Sept. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that Dr.
View HTML
Toggle Summary Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing
MINNEAPOLIS , March 12, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that it has appointed Kevin Hungerford as Global Vice President of Sales and Marketing, effective immediately.
View HTML
Toggle Summary Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith
MINNEAPOLIS , Sept. 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has bolstered its Scientific Advisory Board with the appointment of Dr.
View HTML
Toggle Summary Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD
MINNEAPOLIS , Oct. 11, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Hector J. Gomez , President & CEO, Co-Founder of GLG
View HTML